Reimbursement Woes Could Impact Charité Sales – Spine Surgeon Blumenthal
This article was originally published in The Gray Sheet
Executive Summary
Third-party payor reluctance to reimburse for Johnson & Johnson/DePuy's Charité total artificial disc could hinder its adoption, the device's principal investigator, Scott Blumenthal, MD, Texas Back Institute, contends
You may also be interested in...
Financings In Brief
Spinal Motion: Series B financing of $20 mil. will fund enrollment of the firm's SpinalMotion Kineflex lumbar disc and SpinalMotion Kineflex-C cervical disc U.S. clinical trials, President & CEO David Hovda says. The lumbar disc study, to take place at 25 centers, will seek to prove SpinalMotion Kineflex is substantially equivalent to Johnson & Johnson/DePuy's Charité - currently the only FDA-approved artificial spine disc (1"The Gray Sheet" Jan. 17, 2005, p. 15). The cervical disc trial will involve 20 sites and compare the Spinal Motion product to spinal fusion. Three Arch Partners and Thomas Weisel Healthcare Venture Partners participated in the funding round...
Financings In Brief
Spinal Motion: Series B financing of $20 mil. will fund enrollment of the firm's SpinalMotion Kineflex lumbar disc and SpinalMotion Kineflex-C cervical disc U.S. clinical trials, President & CEO David Hovda says. The lumbar disc study, to take place at 25 centers, will seek to prove SpinalMotion Kineflex is substantially equivalent to Johnson & Johnson/DePuy's Charité - currently the only FDA-approved artificial spine disc (1"The Gray Sheet" Jan. 17, 2005, p. 15). The cervical disc trial will involve 20 sites and compare the Spinal Motion product to spinal fusion. Three Arch Partners and Thomas Weisel Healthcare Venture Partners participated in the funding round...
Is CMS Charitably Inclined Toward DePuy Spine Disc? Other Payors Take Heed
Johnson & Johnson/DePuy will submit hospital claims data to CMS in an effort to convince the agency that the Charité artificial spine disc yields better outcomes for Medicare patients when compared with fusion